Its activation may also be an aggravating factor leading to further neurodegeneration and excitotoxicity in Parkinson’s disease (PD), and is associated with abnormal deposition of alpha-synuclein (α-Syn) [16]. This evidence concerns the gene SNCA and Parkinson disease.